47 filings
8-K
INMB
INmune Bio Inc
17 Dec 19
Regulation FD Disclosure
4:53pm
8-K
INMB
INmune Bio Inc
3 Dec 19
INmune Bio, Inc. Announces First Alzheimer’s Disease Patient Dosed in XPro1595 Study
4:06pm
8-K
INMB
INmune Bio Inc
29 Nov 19
INmune Bio Inc. to Discuss Potential New Alzheimer’s Disease Treatments in CTAD Pre-Conference Webinar
4:13pm
8-K
INMB
INmune Bio Inc
20 Nov 19
INmune Bio, Inc. Strengthens Board of Directors with Appointment of Veteran Finance Executive Marcia Allen
4:30pm
8-K
INMB
INmune Bio Inc
12 Nov 19
INmune Bio, Inc. Reports Third Quarter 2019 Financial Results and Provides Shareholder Update
4:47pm
8-K
zrb5m f4hh0fohxz
21 Oct 19
INmune Bio, Inc. Announces Presentation of Data Related to its Lead Compound XPro1595 at the Society for Neuroscience’s Annual Meeting
6:11am
8-K
3x6nk9bohexydnf8hl9
8 Oct 19
INmune Bio Inc. to Present at Advances in Immuno-Oncology USA Congress and at World Immunotherapy Congress in October
4:30pm
8-K
2zlln194htzp4d
30 Sep 19
Accomplishments at Nasdaq’s MarketSite and Announces Presentation at World Immunotherapy Congress
12:00am
8-K
krvm41
23 Sep 19
Regulation FD Disclosure
4:59pm
8-K
ogosc
18 Sep 19
Regulation FD Disclosure
4:30pm
8-K
58h awiebli22iyiq4b
12 Sep 19
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
o9c3r
12 Sep 19
Inmune Bio Inc. Announces Uspto Allowance of Key Patent Covering Its DN-TNFΑ Platform Technology for Treating Cancer
4:30pm
8-K
ba3bqovq01uiu0u
9 Sep 19
Regulation FD Disclosure
4:31pm
8-K
o3xa7h
4 Sep 19
INmune Bio Inc. to Introduce NeuLiv™ Program for Treatment of NASH
4:30pm
8-K
0n9 jbpb4vdvinca
27 Aug 19
Regulation FD Disclosure
5:00pm
8-K
zb22nox0vj tewkbvx5
15 Aug 19
Regulation FD Disclosure
12:00am
8-K
2s8mwbrs
13 Aug 19
INmune Bio Reports Second Quarter 2019 Financial Results and Provides Shareholder Update
4:36pm
8-K
i1a6q 0xcc
9 Aug 19
INmune Bio Appoints Biotechnology Executive Edgardo Baracchini as New Board Member
4:38pm
8-K
zk10nu 2mf
7 Aug 19
INmune Bio Reports Positive Preliminary Data from INB03 Phase I Clinical Trial in Cancer
4:30pm
8-K
9g6ajcu6u
1 Aug 19
INmune Bio Co-Founder and CEO RJ Tesi Presents at Cambridge Healthcare Institute’s 7th Annual Immuno-Oncology Summit
4:30pm